Okafor
TL3 Regular · Pisa, IT
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 20 December 2024 · last posted 2d · groups: journal-club
122Posts here
2Topics
0Solutions
3.7kLikes received
1.7kLikes given
27Badges
395Days visited
9.9kPosts read
Most-liked posts
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #18 · Safety › Contraindications · 23 Apr 2026 · 33 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. The evidence for this is thinner than…
-
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #6 · Practice › Side effects · 15 Mar 2026 · 32 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
The mass-error checker and its intended scope Replied, post #94 · Data & Tools › Calculators · 3 Jul 2024 · 31 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #7 · Compounds › Oral incretins · 18 Jul 2026 · 30 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #17 · Compounds › Oral incretins · 28 Dec 2025 · 30 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Follow-up: Why appetite effects are mostly central Replied, post #63 · Pharmacology › Receptor biology · 10 Oct 2025 · 30 likes Narrowing post #60, because the general version has more than one answer. Cross-reactivity and selectivity: the compounds are not perfectly selective for their target…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| First Reply | bronze | 21 Dec 2024 |
| Basic User | bronze | 22 Dec 2024 |
| Read the Guidelines | bronze | 25 Dec 2024 |
| Welcome | bronze | 31 Dec 2024 |
| First Topic | bronze | 7 Jan 2025 |
| First Quote | bronze | 10 Jan 2025 |
| Member | bronze | 11 Jan 2025 |
| First Tag | bronze | 15 Jan 2025 |
| First Link | bronze | 16 Jan 2025 |
| Sourced | bronze | 25 Jan 2025 |
| Editor | bronze | 12 Feb 2025 |
| Reader | bronze | 1 Mar 2025 |
| Generous | bronze | 11 Mar 2025 |
| Good Topic | silver | 13 Mar 2025 |
| Journal Club | bronze | 29 Mar 2025 |
| Nice Topic | bronze | 31 Mar 2025 |
| Nice Post | bronze | 4 Apr 2025 |
| Absolute Numbers | silver | 4 Apr 2025 |
| Thank You | silver | 13 Jul 2025 |
| Well Sourced | silver | 21 Jul 2025 |
| Consistently Generous | silver | 11 Aug 2025 |
| Regular | silver | 24 Aug 2025 |
| Journal Club Regular | silver | 24 Aug 2025 |
| Good Post | silver | 5 Oct 2025 |
| Read the Protocol | silver | 9 Oct 2025 |
| Anniversary | silver | 20 Dec 2025 |
| Gives Back | gold | 11 Apr 2026 |